Related Experiment Video
Updated: Jun 27, 2026

The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
Angiotensin-converting enzyme genotype and encephalopathy in Chernobyl cleanup workers
A D Kehoe1, A M Nikiforov, S S Alexanin
1UCL Institute for Human Health and Performance, UCL Archway Campus, Archway, London, UK. anthonyke-hoe@hotmail.com
The angiotensin-converting enzyme (ACE) D-allele is linked to dyscirculatory encephalopathy (DE) in Chernobyl cleanup workers (CCW). This suggests the renin-angiotensin system (RAS) plays a key role in DE development for this population.
Area of Science:
- Genetics
- Neurology
- Cardiovascular Science
Background:
- The renin-angiotensin system (RAS) is crucial for cardiovascular regulation.
- Dyscirculatory encephalopathy (DE) is a neurological condition affecting cognitive function.
- Chernobyl cleanup workers (CCW) represent a population potentially at risk for long-term health issues.
Purpose of the Study:
- To investigate the role of the renin-angiotensin system (RAS) in the development of dyscirculatory encephalopathy (DE).
- To examine the association between angiotensin-converting enzyme (ACE) gene polymorphism and DE in Chernobyl cleanup workers (CCW).
Main Methods:
- A genetic model was employed to study 93 male Caucasian CCW.
- ACE gene polymorphism (insertion/deletion) was determined.
- DE status was assessed based on institutional guidelines.
Main Results:
- A significantly higher frequency of the ACE D-allele was observed in CCW with DE (56.8%) compared to those without DE (35.9%).
- The genotype distribution differed significantly between CCW with and without DE (P = 0.02).
- The ACE D-allele is associated with increased ACE activity, suggesting a higher RAS activity in affected individuals.
Conclusions:
- This study provides the first evidence linking the ACE D-allele to DE in CCW.
- The findings highlight a significant role for the RAS in the pathogenesis of DE.
- ACE inhibition therapy may be beneficial for CCW at risk of or experiencing DE.
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Hepatic Encephalopathy
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu